NEW YORK (GenomeWeb News) – A collection of London research institutes and hospitals have banded together to launch an initiative to develop genetically tailored treatments for thousands of lung cancer patients, the Institute for Cancer Research said today.

The partners involved in the new London Lung Cancer Alliance plan to use tumor sequencing and genetic testing to personalize treatments for up to 3,000 lung cancer patients a year in London and in five other cities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.